The genome of Onchocerca volvulus, agent of river blindness

Area of Science:

• Parasitology
• Genomics
• Tropical Medicine

Background:

• Human onchocerciasis is a neglected tropical disease causing blindness and disability.
• Current control relies on a single drug, necessitating new therapeutic strategies.
• Understanding parasite biology is crucial for developing novel drugs and vaccines.

Purpose of the Study:

• To provide the highest-quality genome sequence assembly for Onchocerca volvulus and its Wolbachia endosymbiont.
• To investigate gene families for potential drug targets.
• To identify essential enzymes and repurposable drug targets for anti-onchocerciasis drug development.

Main Methods:

• Whole-genome sequencing and assembly of O. volvulus and its endosymbiont.
• Comparative genomics to analyze gene families and evolutionary patterns.
• Metabolic reconstruction to identify essential enzymes and potential drug targets.

Main Results:

• Generation of the highest-quality genome sequence assembly for a parasitic nematode to date.
• Identification of gene families with potential for drug target exploitation.
• Discovery of essential enzymes for O. volvulus viability and a list of repurposable drug targets.

Conclusions:

• The O. volvulus genome provides a valuable resource for understanding filarial parasite evolution and biology.
• This study identifies key targets for the development of new anti-onchocerciasis drugs.
• Repurposing existing FDA-approved drugs offers a promising strategy for rapid therapeutic intervention.